Food And Drug Administration Approves Brand New Libido-Boosting Drug for Premenopausal Women

Food And Drug Administration Approves Brand New Libido-Boosting Drug for Premenopausal Women

The usa Food and Drug management (Food And Drug Administration) today authorized bremelanotide (Vyleesi, AMAG Pharmaceuticals), a melanocortin that is first-in-class receptor agonist for hypoactive sexual desire disorder (HSDD) in premenopausal females.

It joins flibanserin (Addyi, Sprout Pharmaceuticals), the actual only real other FDA-approved HSDD treatment plan for premenopausal women. Continue reading “Food And Drug Administration Approves Brand New Libido-Boosting Drug for Premenopausal Women”